GC Wellbeing Acetaminophen Injection

Adult administration

Adults weighing 50 kg or more Administer 1000 mg of acetaminophen, 4 times a day Dosing interval: at least every 4 hours Maximum daily dose: not to exceed 4 grams Adults weighing between 33 kg and 50 kg Administer approximately 15 mg/kg of acetaminophen per single dose Dosing interval: at least every 4 hours Maximum daily dose: 60 mg/kg or not to exceed 4 grams Severe kidney impairment patients (creatinine clearance

Child administration

Pediatric patients weighing 33 kg (approximately 11 years old) or more Administer about 15 mg/kg of acetaminophen per single dose Dosing interval: at least every 4 hours Maximum daily dose: 60 mg/kg or not to exceed 4 grams

This medication must be administered at the exact dosage, as confusion between milligrams and milliliters can lead to serious poisoning or death. Once oral medication can be taken, it is advisable to use appropriate analgesics as soon as possible. It is essential to check if other medications being taken contain acetaminophen to avoid overdose. Exceeding the recommended dosage can cause serious liver damage; therefore, patients with liver function issues or liver disease should only take this medication after consulting a physician. Individuals who frequently consume alcohol should consult a healthcare professional before taking this medication due to the risk of liver damage. If serious skin reactions such as rashes or allergic reactions occur during the use of this medication, ingestion must be stopped immediately and medical advice sought. Patients with hypersensitivity to acetaminophen or this medication, as well as those with peptic ulcers, severe blood disorders, liver, kidney, or heart diseases, should not take this medication. Patients taking aspirin, certain antidepressants, or barbiturates should also avoid this medication. Careful use is required for those with liver or kidney problems, bleeding tendencies, hypersensitivity, asthma, the elderly, pregnant or breastfeeding women, and consultations with specialists are necessary before use. This medication may rarely cause side effects such as blood disorders, liver dysfunction, neurological issues, skin rashes, and injection site reactions, and immediate reporting of any unusual symptoms is important. Interactions may occur when taken with other medications, so inform the physician or pharmacist of any medications being taken. Caution is particularly needed when co-administered with probenecid, salicylamide, isoniazid, carbamazepine, phenytoin, and oral anticoagulants. This medication does not affect driving or machine operation and should not be mixed with other medications. Children and the elderly should take minimal dosages and be monitored for adverse reactions, especially if experiencing high fever. During pregnancy, the use of this medication is limited, but it should be administered cautiously under a physician's judgment if necessary, and it can be used safely while breastfeeding. Patients with severely impaired kidney function should increase the dosing interval. In cases of overdose, symptoms such as nausea, vomiting, and abdominal pain may occur, and in severe cases, can lead to liver damage or coma, necessitating immediate hospital treatment. This medication should not be stored at temperatures above 30 degrees Celsius, and refrigeration or freezing should be avoided. Prior to use, ensure there are no abnormalities in the solution, and any remaining solution after a single use should be discarded.

Serious side effects

Hives, severe swelling (edema), anaphylactic shock, shock, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute renal failure, fulminant hepatitis, liver necrosis, liver failure, angioedema, anaphylaxis, liver abnormalities (jaundice), agranulocytosis, neutropenia, leukopenia, thrombocytopenia, Lyell syndrome, coma, liver toxicity, severe edema, or urination abnormalities

Mild side effects

Fatigue, hypotension, increased liver transaminase levels, neurological disorders, maculopapular rash, injection site reactions, morbilliform rash, similar to pemphigus reactions, pustular rash, nausea, vomiting, headache, constipation, phlegm, sensory abnormalities, dizziness, reduced hemoglobin, urination disorders, thrombocytopenia, tachycardia, nausea, erythema, flushing, itching, rash, hives, high anion gap metabolic acidosis (HAGMA)

This medication should be stored in a sealed container to prevent air and moisture from entering, at a safe temperature between 1 to 30 degrees Celsius. Therefore, it is important to avoid direct sunlight and not to place it in excessively hot or cold locations to maintain efficacy and prevent deterioration.

Appearance

A clear, colorless to pale yellow solution in a plastic vial for injection

Package unit

100 milliliters/pack